Renal Cancer - Results from #920

Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus. May 23, 2023

Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting? May 22, 2023

Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis. May 22, 2023

Differentiating Benign From Malignant Cystic Renal Masses: A Feasibility Study of Computed Tomography Texture-Based Machine Learning Algorithms. May 19, 2023

Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement. May 19, 2023

Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database. May 18, 2023

Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis. May 18, 2023

Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. May 17, 2023

Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study. May 17, 2023

Qualitative Assessment of Contrast-Enhanced Ultrasound in Differentiating Clear Cell Renal Cell Carcinoma and Oncocytoma. May 16, 2023

Meta analysis of clinical prognosis of radiofrequency ablation versus partial nephrectomy in the treatment of early renal cell carcinoma. May 16, 2023

Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients May 15, 2023

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma. May 15, 2023

MicroRNA-155-5p Targets JADE-1, Promoting Proliferation, Migration, and Invasion in Clear Cell Renal Cell Carcinoma Cells. May 15, 2023

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma. May 12, 2023

Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. May 12, 2023

First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis. May 11, 2023

Trends in cause of death among patients with renal cell carcinoma in the United States: a SEER-based study. May 11, 2023

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma. May 10, 2023

The effectiveness of partial versus radical nephrectomy for pT3aN0M0 renal cell carcinoma: A propensity score analysis. May 10, 2023

Page 47 of 456